Genome-based identification of diagnostic molecular markers for human lung carcinomas by PLS-DA
- 30 June 2005
- journal article
- Published by Elsevier BV in Computational Biology and Chemistry
- Vol. 29 (3), 183-195
- https://doi.org/10.1016/j.compbiolchem.2005.04.005
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Differential Expression of MUC1, MUC2, and MUC5AC in Carcinomas of Various SitesAmerican Journal of Clinical Pathology, 2004
- Liver fatty acid binding protein expression in colorectal neoplasiaBritish Journal of Cancer, 2004
- Potentialities of multivariate approaches in genome‐based cancer research: identification of candidate genes for new diagnostics by PLS discriminant analysisJournal of Chemometrics, 2004
- PCA disjoint models for multiclass cancer analysis using gene expression dataBioinformatics, 2003
- A Bioinformatic Approach to the Identification of Candidate Genes for the Development of New Cancer DiagnosticsBiological Chemistry, 2003
- Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclassesProceedings of the National Academy of Sciences of the United States of America, 2001
- Shortcuts in genome-scale cancer pharmacology research from multivariate analysis of the National Cancer Institute gene expression databaseBiochemical Pharmacology, 2001
- A multivariate insight into the in vitro antitumour screen database of the National Cancer Institute: classification of compounds, similarities among cell lines and the influence of molecular targets.Journal of Computer-Aided Molecular Design, 2001
- AIS is an oncogene amplified in squamous cell carcinomaProceedings of the National Academy of Sciences of the United States of America, 2000
- The value of neuroendocrine markers in non-small cell lung cancer: a comparative immunohistopathologic studyLung Cancer, 1994